Endocannabinoid signaling in the amygdala: anatomy, synaptic signaling, behavior, and adaptations to stress.
- Authors
- Ramikie, T S; Patel, S
- Year
- 2012
- Journal
- Neuroscience
- PMID
- 21884761
- DOI
- 10.1016/j.neuroscience.2011.08.037
- PMCID
- PMC3236282
The molecular constituents of endocannabinoid (eCB) signaling are abundantly expressed within the mammalian amygdaloid complex, consistent with the robust role of eCB signaling in the modulation of emotional behavior, learning, and stress-response physiology. Here, we detail the anatomical distribution of eCB signaling machinery in the amygdala and the role of this system in the modulation of excitatory and inhibitory neuroplasticity in this region. We also summarize recent findings demonstrating dynamic alternations in eCB signaling that occur in response to stress exposure, as well as known behavioral consequences of eCB-mediated modulation of amygdala function. Finally, we discuss how integrating anatomical and physiological data regarding eCB signaling in the amygdala could help elucidate common functional motifs of this system in relation to broader forebrain function.
(a) Schematic diagram depicting the regional heterogeneity in the expression of the molecular components of eCB signaling between different amygdala subnuclei. The localization of DAGLα, CB1 receptors, FAAH and MGL are depicted based on data summarized in the in the text. (b) Left top inset: diagram of the amygdala with simplified cellular organization. BLA projection neuron in black, GABAergic interneuron in yellow, and glutamatergic inputs in grey. Boxed area is expanded in the main figure. Synaptic localization of eCB signaling components in a schematized BLA neuron receiving synaptic inputs from a GABAergic interneuron, and glutamatergic input from the external capsule. Known forms of eCB-mediated synaptic signaling at these synapses are overlaid, and specific eCB ligands noted where data is available.
A highly simplified schematic diagram of a common eCB signaling motif expressed across different cortical territories and their associated parallel cortico-striato-pallidal circuits. In “motor” circuits, cortical glutamatergic pyramidal cells (red), synapse onto striatal neurons, and are subject to eCB-mediated retrograde suppression of glutamate release (indicated by green line). GABAergic (black) striatal neurons send projections to the globus pallidus, which is also subject to eCB-mediated retrograde suppression of GABA release. Thus, each stage of the motor circuit is modulated by eCB signaling. A similar motif is evident within “limbic” cortical regions such as the PFC, and we suggest a similar motif may exist within the amygdala circuit. These limbic parallel circuits also exhibit a high degree of interaction, as indicated by the cross projections between and from, the PFC and BLA. (?) Indicates lack of experimental data.
No entities extracted from this document yet.
No uploaded files.
In this knowledge base
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| Alteration of brain endocannabinoids on restraint stress-induced anxiety-like behaviors in mice. | Fukumori R et al. | — | 2026 | → |
| Cannabinoid Receptors in the Horse Lateral Nucleus of the Amygdala: A Potential Target for Ameliorating Pain Perception, Stress and Anxiety in Horses. | Bombardi C et al. | — | 2025 | → |
| Endocannabinoids at the synapse and beyond: implications for neuropsychiatric disease pathophysiology and treatment. | Scheyer A et al. | — | 2023 | → |
| Induction of Anxiety-Like Phenotypes by Knockdown of Cannabinoid Type-1 Receptors in the Amygdala of Marmosets. | Zhu L et al. | — | 2023 | → |
| Acetaminophen and pregabalin attenuate central sensitization in rodent models of nociplastic widespread pain. | Yajima M et al. | — | 2022 | → |
| An interaction between basolateral amygdala orexinergic and endocannabinoid systems in inducing anti-nociception in the rat formalin test. | Deli SB et al. | — | 2022 | → |
| Induction of Anxiety-Like Phenotypes by Knockout of Cannabinoid Type-1 Receptor in Amygdala of Marmosets | Zheng D et al. | — | 2022 | — |
| Subregional Differences in Alcohol Modulation of Central Amygdala Neurocircuitry. | Melkumyan M et al. | — | 2022 | → |
| Fatty acid amide hydrolase binding is inversely correlated with amygdalar functional connectivity: a combined positron emission tomography and magnetic resonance imaging study in healthy individuals. | Green DGJ et al. | — | 2021 | → |
| Investigating the role of CB1 endocannabinoid transmission in the anti-fear and anxiolytic-like effects of ventromedial prefrontal cortex deep brain stimulation. | Gidyk DC et al. | — | 2021 | → |
| Peripheral Guanylate Cyclase-C modulation of corticolimbic activation and corticotropin-releasing factor signaling in a rat model of stress-induced colonic hypersensitivity. | Ligon CO et al. | — | 2021 | → |
| The role of endocannabinoid system and TRPV1 receptors in the antidepressant and anxiolytic effects of dipyrone in chronic unpredictable mild stress in mice. | Topuz RD et al. | — | 2021 | → |
| Association of cannabinoid receptor genes (<i>CNR1 and CNR2</i>) polymorphisms and panic disorder. | Peiró AM et al. | — | 2020 | → |
| Endocannabinoid modulating drugs improve anxiety but not the expression of conditioned fear in a rodent model of post-traumatic stress disorder. | Vimalanathan A et al. | — | 2020 | → |
| Remote CB1 receptor antagonist administration reveals multiple sites of tonic and phasic endocannabinoid neuroendocrine regulation. | Newsom RJ et al. | — | 2020 | → |
| Endocannabinoid Signaling in the Central Amygdala and Bed Nucleus of the Stria Terminalis: Implications for the Pathophysiology and Treatment of Alcohol Use Disorder. | Bedse G et al. | — | 2019 | → |
| Role of the Bed Nucleus of the Stria Terminalis in PTSD: Insights From Preclinical Models. | Miles OW et al. | — | 2019 | → |
| Upregulation of Anandamide Hydrolysis in the Basolateral Complex of Amygdala Reduces Fear Memory Expression and Indices of Stress and Anxiety. | Morena M et al. | — | 2019 | → |
| Inhibition of fatty acid amide hydrolase in the central amygdala alleviates co-morbid expression of innate anxiety and excessive alcohol intake. | Stopponi S et al. | — | 2018 | → |
| Integrating Endocannabinoid Signaling and Cannabinoids into the Biology and Treatment of Posttraumatic Stress Disorder. | Hill MN et al. | — | 2018 | → |
| Stress-Induced Functional Alterations in Amygdala: Implications for Neuropsychiatric Diseases. | Zhang X et al. | — | 2018 | → |
| Addressing sufficiency of the CB1 receptor for endocannabinoid-mediated functions through conditional genetic rescue in forebrain GABAergic neurons. | Remmers F et al. | — | 2017 | → |
| Endocannabinoid signaling and memory dynamics: A synaptic perspective. | Drumond A et al. | — | 2017 | → |
| Regulation of fear extinction by long-term depression: The roles of endocannabinoids and brain derived neurotrophic factor. | Bennett MR et al. | — | 2017 | → |
| The Endocannabinoid System and Anxiety. | Lisboa SF et al. | — | 2017 | → |
| 2-arachidonoylglycerol signaling impairs short-term fear extinction. | Hartley ND et al. | — | 2016 | → |
| Chronic ethanol exposure decreases CB1 receptor function at GABAergic synapses in the rat central amygdala. | Varodayan FP et al. | — | 2016 | → |
| Emotional arousal state influences the ability of amygdalar endocannabinoid signaling to modulate anxiety. | Morena M et al. | — | 2016 | → |
| Endocannabinoid Modulation of Predator Stress-Induced Long-Term Anxiety in Rats. | Lim J et al. | — | 2016 | → |
| Neurobiological Interactions Between Stress and the Endocannabinoid System. | Morena M et al. | — | 2016 | → |
| Reductions in circulating endocannabinoid 2-arachidonoylglycerol levels in healthy human subjects exposed to chronic stressors. | Yi B et al. | — | 2016 | → |
| Targeting the endocannabinoid system to treat anxiety-related disorders. | Korem N et al. | — | 2016 | → |
| The association between cannabis use and anxiety disorders: Results from a population-based representative sample. | Feingold D et al. | — | 2016 | → |
| Cannabinoid functions in the amygdala contribute to conditioned fear memory in streptozotocin-induced diabetic mice: Interaction with glutamatergic functions. | Ikeda H et al. | — | 2015 | → |
| Long-term disease-modifying effect of the endocannabinoid agonist WIN55,212-2 in a rat model of audiogenic epilepsy. | Vinogradova LV et al. | — | 2015 | → |
| Monoacylglycerol lipase (MGLL) polymorphism rs604300 interacts with childhood adversity to predict cannabis dependence symptoms and amygdala habituation: Evidence from an endocannabinoid system-level analysis. | Carey CE et al. | — | 2015 | → |
| The endocannabinoid system and associative learning and memory in zebrafish. | Ruhl T et al. | — | 2015 | → |
| Biological substrates of addiction. | Joffe ME et al. | — | 2014 | → |
| Multiple mechanistically distinct modes of endocannabinoid mobilization at central amygdala glutamatergic synapses. | Ramikie TS et al. | — | 2014 | → |
| The endocannabinoid system: an emotional buffer in the modulation of memory function. | Morena M et al. | — | 2014 | → |
| Amygdala FAAH and anandamide: mediating protection and recovery from stress. | Gunduz-Cinar O et al. | — | 2013 | → |
| Disruption of fatty acid amide hydrolase activity prevents the effects of chronic stress on anxiety and amygdalar microstructure. | Hill MN et al. | — | 2013 | → |
| Lack of interaction of endocannabinoids and 5-HT(3) neurotransmission in associative fear circuits of the amygdala: evidence from electrophysiological and behavioural experiments. | Höfelmann D et al. | — | 2013 | → |
| Phencyclidine-induced social withdrawal results from deficient stimulation of cannabinoid CB₁ receptors: implications for schizophrenia. | Seillier A et al. | — | 2013 | → |
| Endocannabinoids in nervous system health and disease: the big picture in a nutshell. | Skaper SD et al. | — | 2012 | → |
| Introduction to the special issue on stress, emotional behavior, and the endocannabinoid system: a decade of research. | Hill MN | — | 2012 | → |
| Involvement of descending serotonergic and noradrenergic pathways in CB1 receptor-mediated antinociception. | Dogrul A et al. | — | 2012 | → |
| Neuronal populations mediating the effects of endocannabinoids on stress and emotionality. | Häring M et al. | — | 2012 | → |